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Executive Summary
The prevalence of diabetes is on the rise and this demand for services challenges health
care organizations to provide quality, cost-effective care. The current system and processes at
St. Joseph’s Area Health Services (SJAHS) needed redesigning to optimize quality diabetes care.
This necessitated the need to move forward with a systems change project to transform diabetes
care. The purpose of this study was to compare outcomes on glycemic control between current
practice and a diabetes evidence-based practice toolkit by collecting retrospective data pre and
post-toolkit implementation. The review of the literature from 2003-2011 endorsed the need to
evaluate an innovation that incorporates a multidisciplinary, comprehensive, patient-focused
approach to improve glycemic control. There is limited research on glycemic control for the
hospitalized noncritical medical patient. The literature supported further research to generate
additional scientific knowledge surrounding glycemic control in the hospital setting. The
innovation was a toolkit composed of several tools to support the implementation of a
comprehensive, multidisciplinary plan of care for the patient with diabetes. The toolkit provided
the structure and processes to optimize diabetes care in the hospital setting. The study sample
included 168 hospitalized adult patients with an age range of 20-95 and a mean age of 69.8, all
with a diabetes diagnosis, and insulin therapy. The results indicated there was not a significant
decrease in glycemic control from pre-toolkit to post-toolkit implementation timeframes. The
findings suggested that the toolkit has not been adopted by all members of the health care team
therefore glycemic control did not improve with toolkit implementation. Despite the results
SJAHS has the elements to be successful with this innovation and based upon the knowledge we
have gained we are on a journey to improve diabetes care. The findings will be utilized to
determine next steps in regards to the toolkit as an innovation to improve diabetes care.
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An Innovation to Transform Diabetes Care
Diabetes affects 25.8 million people in the United States, an increase of more than three
million in approximately two years (Center for Disease Control and Prevention [CDC], 2011).
This means that nearly eight percent of the U.S. population has a diabetes diagnosis. Diabetes is
the seventh leading cause of death in the country and can cause serious health complications
(CDC, 2008). People with diabetes are more likely to be hospitalized and to have longer hospital
stays than those without diabetes (Moghissi et al., 2009). Nearly three million people with
diabetes are hospitalized annually (Lange, 2010). It has been estimated that 22 percent of all
inpatient days in 2008 were incurred by patients with diabetes at a cost of 87 billion dollars for
expenses related to diabetes care. This accounts for half of the 174 billion dollars spent on
medical treatment of diabetes (Moghissi et al., 2009). The readmission rate is also greater for
patients with diabetes (American Association of Clinical Endocrinologists [AACE], 2011).
In addition to cost there is evidence linking hyperglycemia in hospitalized patients to
adverse outcomes (Moghissi et al., 2009). In 2004, recommendations for the treatment of
inpatient hyperglycemia were developed by the American College of Endocrinology (ACE) and
the American Association of Clinical Endocrinologists (AACE) in collaboration with the
American Diabetes Association (ADA). An updated consensus statement on inpatient glycemic
management was developed by AACE and ADA in 2009 and reviewed by the ADA in 2010
(ADA, 2011). There is a growing health care movement promoting the management of inpatient
hyperglycemia as a quality measure (Moghissi et al., 2009). According to the Institute for
Health Care Improvement (IHI) (2010) innovative systems change initiatives are critical to
address diabetes and its consequences. Health care organizations are beginning to realize that
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there is a need to redesign systems and processes that will optimize diabetes care (Manchester,
2008).
Problem Statement
At St. Joseph’s Area Health Services (SJAHS) the management of diabetes on the
medical unit was physician dependent and varied greatly. The current system does not support a
patient care process that is comprehensive, multidisciplinary, nor patient focused. Updated tools
are needed utilizing current inpatient glycemic management evidence to support consistent
medical and nursing practice. This necessitated a need to move forward with a systems change
innovation to transform the management of diabetes care.
Key stakeholders at SJAHS recognized that there was a need to improve diabetes care.
The key stakeholders were; nursing, physicians, certified diabetes educators, and pharmacy.
The stakeholders mobilized commitment by organizing a multidisciplinary team to design and
implement a systems change innovation to promote quality diabetes care. Patients have the right
to receive quality evidence-based care (American Nurses Association [ANA], 2001).
Professionals need to create an environment that is ethical and just within the health care system
(ANA, 2001). From the nursing perspective nurses are obligated to provide quality diabetes
care. Nursing is in the position to change the social structures such as a specific hospital setting
that detracts from health and well-being (ANA, 2001). SJAHS is the social structure where there
is a desire and obligation to improve the standard of care that is provided to patients with
diabetes. Collaboration and “planning is required to ensure the availability and accessibility to
quality health care services to all persons who have a need for health care” (Kalb, 2009, p.2.).
Patients with diabetes at SJAHS are not receiving the level of care that they deserve; this is an
example of a health care disparity. This has not been an intentional gap in quality. Our current
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system lacks the structure and processes to provide quality diabetes care. In a complicated
situation such as this, actions, reactions, and interactions matter greatly (Patton, 2011). The
stakeholders at SJAHS had the opportunity to transform diabetes care at SJAHS.
Transformation requires leadership. A leader is key to create a moral environment and to
promote social justice within the health care system (White et al., 2011). This innovation
advocated for change that is ethical and adheres to the principle of justice by advocating for
quality diabetes care and equal access to health care by all that receive care at SJAHS.
SJAHS is committed to excellence and identifies quality as one of its key pillars of
strategic success in addition to people, stewardship, and growth. The provision of quality care is
imperative in today’s health care environment. In the United States it is estimated that 30-40 %
of patients do not receive treatments of proven effectiveness (Halm, 2010). Implementing and
evaluating a systems change innovation to improve diabetes management was needed at SJAHS.
The innovation to transform care consisted of a diabetes management toolkit based upon
evidence-based practice. Current best evidence is needed to make clinical decisions about
patient care (Polit & Beck, 2008).
Project Objectives
1. Design and implement a Diabetes Evidence-Based Practice Toolkit for the hospitalized
medical patient with diabetes.
2. Evaluate the outcomes of the toolkit to determine if the systems approach to patient care
improved glycemic control.
3. Utilize the findings to further develop the Diabetes Evidence-Based Practice Toolkit to
generate decision quality and to promote the achievement of safe, quality patient
outcomes.
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Research Questions
1. Among medical adult hospitalized patients, does an organizationally developed evidencebased diabetes care management toolkit in comparison to current practice at SJAHS
improve glycemic control?
2. What are the effects of the toolkit on self-care goals and on patient satisfaction?
3. What is the protocol adherence for hypoglycemia management?
4. Does the toolkit decrease hospital readmissions?
Theoretical and Operational Definitions
Glycemic control is defined in the hospital setting for the noncritical care patient as preprandial blood glucose target <140 mg/dL and a random blood glucose target <180 mg/dL
(Moghissi et al., 2009).
The toolkit was comprised of several evidence-based practice tools to support the
implementation of a comprehensive, multidisciplinary plan of care for the patient with diabetes.
The tools consisted of: subcutaneous insulin orders, hypoglycemia protocol, total parenteral
nutrition (TPN) and enteral tube feeding blood glucose monitoring guidelines, diabetes plan of
care, diabetes patient education/discharge instruction sheet that includes patient identified selfcare goals, discharge planning checklist and guidelines for transition to outpatient care, an
educational plan for physicians, nursing, and other healthcare professionals, and metrics (see
Appendix A for a sampling of the components of the Diabetes Evidence-Based Practice Toolkit).
The toolkit was a quality improvement strategy to provide the structure and processes to deliver
comprehensive diabetes care to optimize glycemic control. “Optimal diabetes management
requires an organized, systematic approach and involvement of a coordinated team of dedicated
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health care professionals working in an environment where patient-centered high-quality care is
a priority” (ADA, 2011, p. S48).
The toolkit was the innovational approach of this systems change project. The toolkit
provided the structure and processes to optimize diabetes care management in the hospital setting
for the medical patient with diabetes.
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Theoretical Framework
This systems change innovation was guided by an organizational change model to
optimize change effectiveness called the Change Acceleration Process (CAP) (General Electric
Corporation [GEC], 2007), the Relationship-Based Care (RBC) model (Manthey, 2006) from the
discipline of nursing, and philosophical elements from the quality improvement theoretical
framework.
Change Acceleration Process Model
The CAP model provides structure to drive action plans and outcomes and a
comprehensive set of tools to assist the change leader in every step of the process moving from
current state to transition to an improved state. This enables the CAP leader to organize a team
to change structures and systems (GEC, 2007). This model provided the structure to promote
organizational change as the key stakeholders embarked on transforming diabetes care at
SJAHS. The CAP model has the potential to guide nursing practice and influence system
change. CAP provides a general framework for accelerating change that is determined by the
work of the key stakeholders. There are seven concepts which are clearly defined and outlined
in a clear simple diagram (see Appendix B for diagram of the CAP Model). The concepts are
interrelated to guide and focus the change process, to launch, and implement a major change
initiative (GEC, 2007). CAP provides the framework and direction for promoting change in a
structured process.
In order for this process to be successful, there needs to be organizational administrative
support and a champion who sponsors the change. The champion (change leader) facilitates a
team who shapes the vision for a desired outcome. “The need for change must exceed its
resistance” (GEC, 2007, p. 18) and “failed change efforts or an inability to change quickly costs
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healthcare organizations millions of dollars annually” (GEC, 2007, p. 110). The stakeholders at
SJAHS had the support of the administrative team to move forward with this systems change
innovation.
The CAP model provides the structure for a transformational leader to produce change
for a systems change innovation. For example, it provided the tools to facilitate change by
mobilizing key stakeholders to determine our vision for excellence in care of the patient with
diabetes in the hospital community. CAP provides structure from inception to implementation
and to the establishment of indicators to measure success (GEC, 2007).
Relationship-Based Care (RBC) Model
This systems change innovation was built upon the foundation of a nursing theory, the
RBC model. This model can be used to guide the transformation of nursing practice and to
propel optimal health care outcomes (Stewart, 2011). According to Manthey (2006), when
interpersonal relationships in a health care organization are healthy the quality of care improves.
The RBC model is based upon the nurse’s relationship with self, patients, patients’ families, and
colleagues; including all relationships within the health care system. These relationships are
interdependent and together optimize health care. In order for these relationships to thrive there
needs to be a caring, healing environment. The health care environment on the medical unit
where the transformation of diabetes care was implemented exhibited these caring attributes,
which supports the RBC philosophy. In RBC, there are six key elements that impact the
healthcare environment: professional nursing, patient care delivery, teamwork, leadership,
resources, and outcome measurement. These elements can be transformed to change practice.
Transformation requires the leader to have a vision, competency, confidence, and commitment,
as well as the ability to collaborate toward a common goal (Stewart, 2011). When these qualities
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are present, there will be goal attainment such as the successful implementation of a systems
change innovation.
The premise of this theory is that relationships are the key to transforming practice;
therefore, this theory has the potential to influence nursing actions and patient care. The RBC
model provides the structure for a systems change innovation to transform care and promote safe
quality patient care.
Quality Improvement Model
This systems change innovation used philosophical elements of continuous quality
improvement as a framework to design, implement, and evaluate effectiveness of the diabetes
evidence-based practice toolkit. There was a strategic focus to improve diabetes care. There
was implementer involvement, the multi-disciplinary team. The patient with diabetes was the
customer of focus to receive quality care. The entire system was viewed as providing a service
and influencing an outcome of improved glycemic control. The team identified a solution, a
diabetes EBP toolkit to guide and enhance overall system performance through process
improvement and organizational learning. Outcomes were measured and the data analyzed to
make improvement decisions (McLaughlin, 2004).
Theoretical Summary
Relationship-Based Care provided the theoretical underpinning of nursing practice for
this systems change innovation; the Change Acceleration Process provided the model to propel
change in the system using a structured approach, and the quality improvement theoretical
framework provided the foundation for promoting continuous organizational quality
improvement. Nursing ethics and social justice, components of all three models, served as
ethical rudders. This foundation provided the theoretical support for a systems change
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innovation. RBC provided the foundation for nursing practice by supporting the structure to
transform practice through inspiration, infrastructure, education, and evidence. RBC also
provided the leader with specific criteria to lead this transformation. RBC and CAP both require
a vision to promote change and a leader with passion and commitment. The vision was shaped
by the team and included ethics and social justice. RBC inspiration promoted movement and
CAP mobilized team commitment. The RBC infrastructure allowed change to occur and the
CAP team had the desire to make the change occur and last. The CAP team established
indicators to measure success and to establish accountability. Evidence of success, according to
RBC, is transformation of practice as evidenced by excellence in patient care outcomes (GEC,
2007; Stewart, 2011). This systems change innovation unfolded and transformed through the
underpinnings and interrelationships of RBC, CAP, quality improvement, ethics, and social
justice.
Literature Review
The review of the literature covered a nine year period from 2003-2011. The search
included several bibliographical databases: MEDLINE, CINAHL, Cochrane Reviews, and
JoAnna Briggs Institute. The search limiting parameters were: adult age group, English
language, and publication type; research including, quasi-experimental, retrospective, and
randomized controlled trials (RCTs). The following key words were used in the search: diabetes
mellitus, hyperglycemia, glycemic control, inpatient management, diabetes care, practice
guidelines, insulin therapy, protocols, multidisciplinary care team, quality health care, toolkit,
and diffusion of innovation. A total of 40 abstracts were reviewed, of which nine met the
inclusion criteria. The criteria for abstract review consisted of: noncritical care inpatients,
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interventions focused on insulin protocols, strategies to augment practice changes, and outcomes
related to glycemic control.
National practice guidelines are another source of evidence for establishing evidencebased care. The search for a guideline on diabetes care management in the hospital setting
included two bibliographical databases, Cochrane Collaboration and National Guideline
Clearinghouse (NGC). The following key words were used in the search: diabetes care, inpatient
management, and practice guidelines. The standard of medical care in diabetes, diabetes care in
the hospital was selected for content review from the NGC database because of the specific
recommendations for the management of hospitalized patients with diabetes.
Of the studies reviewed, the purposes were consistent with the glycemic control research
questions of this innovation. This confirmed that the study was a sensible one that needed
further research. Baldwin et al. (2005) studied inpatient hyperglycemia without the use of
sliding scale insulin (SSI), Johnston and VanHorn (2011) studied tighter glycemic control using
subcutaneous insulin via basal-bolus method versus SSI, whereas others have studied the use of
protocols or standardized order sets (Comi et al., 2009; DeSantis et al., 2006; Umpierrez et al.,
2007) and two in conjunction with a team approach (Comi et al., 2009; DeSantis et al., 2006) or
a multifaceted approach combining a protocol with clinical education and computerized order set
(Schippner et al., 2009). They all had a purpose, to study an intervention to improve glycemic
control or to manage inpatient hyperglycemia.
The interventions consisted of basal-bolus insulin regime (Umpierrez et al., 2007),
comparison of SSI and basal-bolus (Johnston & VanHorn, 2011), insulin protocol guided by
glucose management service (Comi et al., 2009; DeSantis et al., 2006), re-education of house
officers, rounding, and a basal-bolus standard approach (Baldwin et al., 2005), and a
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multifaceted approach with protocol, clinical education, and computerized order set (Schnipper
et al., 2009). All interventions were designed for the specified study site; therefore, the exact
nature of the intervention varied from site to site. This impeded the ability to compare results
across studies or to generalize findings to other settings and populations.
The outcome measurements described in the studies consisted of glycemic control as
evidenced by blood glucose within an identified range, specific glycemic targets, hyperglycemic
events, hypoglycemic events, insulin patterns, process of care (increased use of the basal-bolus
orders), and length of hospital stay. Each study clearly defined their outcome measurements.
The control groups received current clinical care as noted per each organization and outcomes
were compared to the intervention groups. The measures used consisted of blood glucose
results, hemoglobin A1c (HbA1c), insulin doses, and length of stay (LOS). Each study
described how the measures were obtained with some variation, but no major differences. The
measurement period was consistent across all studies measuring blood glucoses during the
subjects hospital stay.
The findings indicated significant improvement in glycemic control as noted in the
studies using a protocol or order set (Baldwin et al., 2005; DeSantis et al., 2006; Umpierrez et
al., 2007) to manage hyperglycemia in the hospital setting for the noncritical care patient with
diabetes or hyperglycemia. Several of the studies also incorporated other strategies to support
glycemic control in each of their respective setting such as: house officer rounding, a glucose
management service, clinical education, and a computerized order set (Baldwin et al., 2005,
Comi et al., 2009, DeSantis et al., 2006, Schnipper et al., 2009). No significant difference in the
rate of hypoglycemia was noted. Schnipper et al. (2009) noted that no increase in hypoglycemic
events is clinically significant as a patient safety outcome. Johnston andVanHorn (2011)
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concluded that blood glucose control in their study was poor, noting insulin therapy needs to be
adjusted and intensified more frequently to obtain better glycemic control. There was a clear
pattern that unfolded from analyzing the studies; a standardized approach provides the
opportunity to improve glycemic control.
Two of the research studies reviewed indirectly supported the relevance of the glycemic
control research questions of this innovation (Dickerson et al., 2003; Finfer et al., 2009). Their
findings offer utility in providing support for further research in regards to glycemic control. The
Dickerson et al. (2003) study findings validated the need to move away from SSI to manage
diabetes in the hospital setting to protocol development using basal-bolus regimes. The Finfer et
al. (2009) study validated the need to consider the consequences of glycemic control related to
hypoglycemia and its potential ramifications including mortality. This study also supported the
need for further research beyond critical care where a majority of glycemic control research has
occurred. A systematic review by Bloomgarden and Mechanick (2007) identified the need for
additional research on glycemic control in the hospital setting especially for the noncritical care
patient.
Synthesis of Findings
To date, there are few published studies that have researched how best to implement
standardized insulin protocols based upon clinical guidelines to improve glycemic control in the
hospital setting for the noncritical care patient. Of the nine studies critically analyzed in this
literature review they all focused on glycemic control using protocols or standing orders in
addition to innovative interventions to augment protocol implementation and thereby improving
glycemic control. The evidence from these nine studies supports the creation of additional
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studies to further advance the spirit of inquiry regarding inpatient glycemic control for the
hospitalized noncritical care patient.
The analyses also conveyed evidence that glycemic control is an important outcome
measure to research. There was evidence that the interventions were effective and clinically
significant for several of the studies, whereas other study findings suggested additional research
is indicated. This judgment is consistent with Manchester (2008) noting that healthcare
organizations need to redesign processes that optimize diabetes care. SSI regimes need to be
replaced with clinical guidelines using a standardized approach such as a protocol for
subcutaneous insulin administration that was a component of the diabetes care management
toolkit. The diabetes EBP toolkit was a multifaceted innovation similar to Schnipper et al.
(2009), but the components were designed and implemented by the stakeholders at SJAHS in
order to meet the needs of the organization and patients served. There are similarities and
differences in each of the research designs, of which, of note helped to further refine the
innovational study design and supported its value in moving forward with the research study.
Integrated Review
Bloomgarden and Meclanick (2007) concluded in their systematic review that it is no
longer appropriate to ignore glucose measurement or to tolerate hyperglycemia in the hospital
setting. Hyperglycemia is associated with adverse outcomes (Moghissi et al., 2009) and is linked
with increased mortality and morbidity (Shogbon & Levy, 2010). Studies have shown the
benefit of intensive glucose management in the critical care patient setting and other studies have
shown equivocal or negative results. For example, the NICE-SUGAR study, a landmark RCT
concluded that intensive glucose control, defined as a target blood glucose range of 81-108,
increased mortality among adults in the ICU (Finfer et al., 2009). Despite the inconsistencies in
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clinical trial results, good glucose management remains an important focus for the hospitalized
patient with diabetes (Moghissi, 2010).
Hypoglycemia is a limiting factor in optimizing glycemic control (Bloomgarden &
Mechanick, 2007). It is also paramount for clinicians to understand the importance of
hypoglycemia management and to monitor patients closely. Glucose management involves
vigilance against hypoglycemic events and attention to prevention and management is essential.
This needs to be considered when redesigning systems and processes for diabetes management.
Inpatient glucose management has been researched more in the critical care setting; there
is limited data on the noncritical care patient population (Shogbon & Levy, 2010). Only a few
studies have been published on the effect of glycemic control on outcomes outside of critical
care (Moghissi et. al., 2009). The complexity of inpatient glycemic control necessitates a
systems approach that facilitates safe practice. To date there are few published studies that have
researched glycemic control using a systems approach that includes a multidisciplinary,
comprehensive approach to diabetes management in the hospital setting on a general medical
unit (ADA, 2011). This is also supported by the literature review. The ADA guidelines (2011)
on inpatient diabetes management as previously discussed is a source of evidence to be used in
conjunction with other sources of evidence to provide the information for organizational
implementation of a practice change. Guidelines have only a small impact on the quality of care
provided to inpatients with diabetes (Wallymahmed et al., 2004), experienced and
knowledgeable staff are essential (Modic, 2010; Moghissi et al., 2009; Wallymahmed et al.
2004) in addition to a multifaceted, comprehensive approach (Schnipper et al., 2009).
There are gaps in clinical knowledge related to inpatient glycemic control particularly
for the noncritical care hospitalized patient as evidenced by the research. There are several areas
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that need further investigation: patient outcomes related to a multifaceted approach to diabetes
inpatient management, what are the benefits of a comprehensive approach, what are the results of
an evidenced-based practice approach; establishment of inpatient glucose metrics for outcome
measurement; and to investigate the innovation related to the clinical questions. ACE (2004)
also identified other areas that need further investigation; the management of stress
hyperglycemia, the causes of severe hypoglycemia, glycemic targets on noncritical care units,
glycemic variability, and safety measures for glycemic control in the hospital system. There are
endless possibilities related to diabetes management in the hospital setting.
All of the evidence reviewed and analyzed provides a solid foundation and together the
evidence provided the strength to support additional outcomes research such as the innovation,
an organizationally developed evidenced-based diabetes care management toolkit. In addition to
evidence the innovation also needed to integrate the values of the organization, clinician
expertise, and the patient’s voice to improve the management of diabetes care in the hospital
setting. The evidence also suggested that further research is a promising action to generate
additional scientific knowledge surrounding glycemic control in the hospital setting.
Summary
Overall there was evidence to support this study using an innovative approach to improve
glycemic control for the hospitalized medical patient with diabetes. There needs to be more
research conducted on glycemic control using a systems approach that includes a
multidisciplinary, comprehensive approach to diabetes care. The recommendation was to
implement an organizationally developed toolkit that is based upon existing research-based
knowledge and best evidence and to evaluate the outcomes of this innovation.

AN INNOVATION TO TRANSFORM

25

This toolkit was designed to improve clinical practice and the health outcomes of the
medical patient with diabetes at SJAHS. The toolkit included the following: an insulin
management protocol to achieve effective and safe glycemic targets, a hypoglycemia treatment
protocol with a focus on prevention, patient education on diabetes in the hospital setting in an
outline format, discharge planning checklist to ensure a safe transition from hospital to
outpatient, educational objectives and course content for physician and nurse education, and
metrics. Each tool was designed in paper format and became a component of the toolkit. All of
these tools are important factors to promote optimal diabetes care through an organized
systematic approach (ADA, 2011).
Organizations can no longer ignore inadequate glycemic control or tolerate
hyperglycemia in the hospital setting (Bloomgarden & Mechanick, 2007). Glycemic control is a
quality measure that needs further development and investigation to ensure safe quality care for
the hospitalized patient with diabetes. This innovational study was supported in the literature
and there was evidence to endorse this systems change project as an innovation to transform
diabetes care.
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Project Design and Methodology
This systems change innovation was designed to accept or reject the hypothesis that
patients receiving diabetes care management using the toolkit will (1) have improved glycemic
control during their hospital stay, (2) have identifiable self-care goals by discharge, (3) be
satisfied with their diabetes care during their hospital stay, (4) have hypoglycemic episodes
managed by nursing using a protocol, and (5) have a decrease in hospital readmissions related to
diabetes within 30 days of discharge. A retrospective chart audit was the method used by the
leader of this innovation to collect data pre-toolkit implementation; June 2010-November 2010
and post-toolkit implementation; June 2011-November 2011.
The chart audit sample was generated from coded data using International Statistical
Classification of Diseases and Related Health Problems (ICD-9) diabetes codes within the
SJAHS Meditech computerized database. All adult patients hospitalized on the medical unit who
received insulin therapy for diabetes were included in the chart audit. The pediatric, critical care,
obstetric, and surgical hospitalized patients were excluded from this study.
The goal was to audit 20 charts per month for a total of 120 for pre-toolkit
implementation and 120 for post-toolkit implementation timeframes. This target was based upon
prior evidence-based practice initiatives implemented at SJAHS. For June 2010-November
2010 a total of 120 patient charts were reviewed, 89 patient charts met inclusion criteria, and 31
were excluded. The excluded were; 23 surgical patients and 8 critical care patients. Among the
120 patient charts reviewed from June 2011-November 2011, 79 patient charts met inclusion
criteria, and 41 were excluded. The excluded were; 29 surgical patients, 10 critical care patients,
and 2 obstetric patients. According to Polit and Beck (2008) outcomes data should be collected
over a sufficient time typically 6-12 months. This allows for a true test of a mature innovation.
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The leader chose a six month period of time to collect data for both pre-toolkit and post-toolkit
timeframes.
A data collection tool was used by the leader to extract data for outcomes research and
formative evaluation. The data extracted included episodes of hyperglycemia > 180 mg/dL and
episodes of hypoglycemia <50 mg/dL. This data was used to compare pre-tool kit glycemic
control to post-toolkit glycemic control. Additional data was abstracted for the post-toolkit
implementation timeframe to address research questions two and three which included self-care
goals documented on discharge and protocol adherence for episodes of hypoglycemia <50
mg/dL. Study sample characteristics were also abstracted including: gender, ethnic group, type
of diabetes, comorbidities, and length of stay (LOS). No patient identification information was
noted on the data collection tool, a subject code was assigned to prevent patient identification
(see Appendix C for the Data Collection Tool).
Outcomes research documents the quality and effectiveness of health care services
(Polit & Beck, 2008). The three factors emphasized are structure, process, and outcomes. These
factors were used to develop metrics for each of the research questions. Outcomes research
terminology is also used by Catholic Health Initiatives (CHI) SJAHS parent company, to provide
the structure for measuring quality improvement initiatives. CHI also includes a person-centered
metric as a required element of the evaluation process. Since SJAHS is a market based
organization of CHI, it is essential to use the same measurement language for metric evaluation.
A metric was designed for each research question.
1. Among medical adult hospitalized patients, does an organizationally developed evidence-

based diabetes care management toolkit in comparison to current practice at SJAHS
improve glycemic control?
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Outcome metrics: The rate of hyperglycemic episodes (>180 mg/dL) among patients
who receive insulin any time during their hospital stay per 1000 patient days (ICSI,
2010). The rate of hypoglycemic episodes (<50 mg/dL) among patients who receive
insulin any time during their hospital stay per 1000 patient days (ICSI, 2010). This
metric was used to measure glycemic control pre and post-toolkit implementation.
2. What are the effects of the toolkit on self-care goals and on patient satisfaction? Personcentered metric: Percent of patients with self-management goals documented at the time
of discharge and post discharge patient satisfaction interview questions. These metrics
were used during the post-toolkit implementation phase.
3. What was the protocol adherence percentage by nursing for hypoglycemia management?
Process metric: Was the hypoglycemia protocol adhered to when there was a
hypoglycemic episode (<50mg/dL)? This metric was used during the post-toolkit
implementation phase.
4. Does the toolkit decrease hospital readmissions? Outcome metric: Was there diabetes
related readmissions within 30 days of discharge for the post-toolkit implementation
phase?
From the data collection tool the data was then transferred into a computerized database,
IBM Statistical Package for the Social Sciences 19 (SPSS), by the leader. The leader checked
the original and transferred data sets to ensure that there were no data entry errors or other data
integrity issues prior to data analysis. The data analysis was conducted in SPSS by a PhD
prepared statistician from Bemidji State University.
Satisfaction with diabetes care was measured during the post-toolkit implementation
phase of the study using a satisfaction questionnaire developed by the leader to obtain the
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patients voice for formative evaluation (see Appendix D for the Patient Satisfaction
Questionnaire). Participant feedback is a common approach for evaluating an innovation
(Patton, 2011) and essential in order to understand and capture the human experience (Polit &
Beck, 2008). Twelve patients hospitalized with diabetes were randomly selected to participate
in a phone interview 1-2 weeks post discharge to collect patient satisfaction data. Patient
consent was obtained; (see Appendix E for a sample of the Consent form). The leader was able
to contact 11 of the 12 within two weeks post discharge to complete the questionnaire via phone.
The twelfth participant was unreachable.
The hospital readmission rate data was obtained using the Meditech database at SJAHS
during the post-toolkit implementation phase. Patients receiving care using the toolkit were
screened on Meditech by the leader to see if they had been readmitted within 30 days of
discharge.
Approval for this research study was obtained from the Institutional Review Board (IRB)
of St. Catherine University prior to beginning the data collection of this systems change
innovation. IRB approval was not required from SJAHS because of the quality improvement
focus of this study to improve patient outcomes. However, administrative and medical staff
support was obtained prior to toolkit development. SJAHS supported this systems change
innovation with the goal to improve diabetes care from the initial inception. Our organizational
commitment to quality, excellence, and evidence-based practice (EBP) gave us the opportunity
to transform diabetes care at SJAHS. CHI also identifies EPB as a priority and supports the
adoption of quality patient care initiatives throughout the entire system. This innovation
supported our vision of a great place to work, a great place to receive health care, and a great
place to practice.

AN INNOVATION TO TRANSFORM

30

Formative Evaluation
The hospital environment is a complicated system. Innovations need evaluation in order
to support ongoing use and dissemination to scale (Patton, 2011). Formative evaluation was
used in concert with outcomes research data to evaluate the toolkit and its impact on improving
glycemic control. The design team established priority questions for evaluating the
effectiveness of the toolkit like the following as described by Patton (2011): does it fit
organizationally; is it transferable to other diabetes patient groups; is it feasible; how was it
received; to what extent were the toolkit components of care followed; what implementation
problems were encountered; how accepting were the other healthcare professionals of the toolkit;
were the metrics selected appropriate; and did we address social justice needs of this population?
Careful and conscientious attention to formative data will give the team the ability to fine tune
the toolkit they have designed in order to workout implementation issues, enhance quality,
determine efficacy, and effectiveness, and standardize the toolkit for summative evaluation
(Patton, 2011).
Implementation Strategies
Timeline. In order to implement a successful systems change innovation the leader
developed a comprehensive timeline that the organization, stakeholders, and staff supported. A
timeline is needed to strategically guide effective transformation. There is an intense amount of
time involved in a systems change innovation. As shown in Table 1, the timeframe for the
diabetes EBP toolkit was from October 2010 to May, 2012.
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Table 1
Diabetes Evidence-Based Practice Toolkit Timeline
Objectives
Develop an evidence-based
practice toolkit for the
hospitalized medical patient
with diabetes.

Implement the Diabetes EBP
Toolkit for the hospitalized
medical patient with diabetes.

Evaluate the outcomes of the
toolkit to determine if the
systems approach to patient
care improves glycemic
control. Utilize the findings to
adopt or adapt the toolkit at
SJAHS.

Activities
1. Interview stakeholders
to identify gaps in the
delivery of quality care
to the patient with
diabetes.
2. Literature review
3. Identify and
conceptualize the
problem.
4. Obtain administrative
approval.
5. Invite key stakeholders
to participate on the
toolkit design team.
6. Submit systems change
proposal.
7. Obtain IRB approval at
SCU.
8. Present proposal to
Patient and Family
Advisory Council.

Timeline
October 2010

November 2010

December 2010
May 2010

Educate physicians
Educate nursing staff and
other health care disciplines.
Set toolkit implementation go
live date.
Collect chart audit data.

April 2011
May 2011

Analyze data
Write up innovation results,
lessons learned and where do
we go from here?
Submit final manuscript
Disseminate findings at
SJAHS and SCU.

January 2012
January 2012

June 2011
July 2011-December 2011

February 2012
May 2012
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Resources. The application of economic principles is essential to ensure successful
implementation of a systems change innovation. The allocation of resources needs to be done in
the most efficient manner (Schafermyer, 2000). Morally and ethically there is the desire to serve
all people, this is how it should be, however due to scarcity of resources this is not possible under
the current United States (U.S.) health care system where market justice prevails (Budetti, 2008).
However, we can do our very best to meet the needs of our community with the implementation
of innovations to generate positive outcomes.
Based upon the prevalence of diabetes in the U.S. there is a demand for diabetes care in
every community and the demand will increase in relation to the predicted increase in diabetes
(CDC, 2011). According to ADA (2005) the prevalence of diabetes among hospitalized patients
is 12%-25%. This was consistent with our estimate of 1-2 patients per day with a diabetes
diagnosis at SJAHS.
An innovation needs to be supported with appropriate resources (Porter-O’Grady &
Malloch, 2011). The resources needed to carry out this systems change innovation were people,
time, and technology. The people resources included; a multidisciplinary team, nursing staff,
medical staff, administration, and a transformational leader to lead this systems change
innovation. The time resources included the time necessary for the people resources to design,
implement, and evaluate the innovation. Technology resources included: word processing,
power point development, and statistical analysis using SPSS.
There are costs associated with resources. SJAHS agreed to financially support this
innovation. The total cost was calculated at $22, 503. This excluded the expenses donated by
Novo Nordisk to cover physician education. This did include an in-kind donation of
approximately $9600 by the leader which could be a cost savings to the organization of $9600.
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Therefore an adjusted cost, excluding the in-kind donation could be $12,903. Table 2 shows the
financial budget developed by the leader to develop, implement, monitor, and evaluate the
toolkit.
Table 2
Finance Budget for Diabetes EBP Toolkit
Resource

Activity

Amount
of time

Number
of
People

Hourly
Rate

Cash
Expense

Toolkit
Development

Team
Meetings

12
hours

9

48.00a

$5184.00

November
2010-April
2011

Leader
Time

24
hours

1

50.00b

In-Kind
Expense

Cost

$1200.00

$6384.00
Materials
Toolkit
Implementation
April 2011May 2011

Education
Classes

$50.00

2 hours

Food

65

36.00c

65

$195.00

Educator
Time

4 hours

3

48.00a

Leader
Time

10
hours

1

50.00b

Physician
Education

$2340.00

$576.00

$500.00

24

In-kind
donation
by Novo
Nordisk,
amount
unknown
$3661.00

Toolkit
Monitoring

Team
Meetings

9 hours

9

48.00a

May 2011December
2011

Leader
Time

18
hours

1

50.00b

$3888.00
$900.00
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$4788.00

Toolkit
Evaluation
July 2011January 2012

Leader
Chart Audit
Time

150
hours

1

50.00

b

$50.00

SPSS
Software
Rental
6 hours
Statistician
Consultation
Services

$7500.00

20.00d

1

$120.00

$7670.00
Total Cost

$22,503

a

Average hourly rate of team members plus benefits
Hourly rate of leader plus benefits
c
Average hourly rate of staff nurse plus benefits
d
Hourly rate of statistician services
b

There are many costs and potential benefits to a systems change innovation and it is
imperative to determine the costs and benefits as another strategy to foster successful
implementation. As shown in Table 3, an outline of the costs and benefits of the toolkit and as
shown in Table 4, an outline of a potential 25% return on investment analysis (ROI) of the
toolkit.
Table 3
Table of Costs and Benefits
Costs

Benefits

Program Costs

Program Benefits

Diabetes Evidence-Based Practice Design Team
meeting time
Facilitator time
Training of all staff

Quality improvement
Staff satisfaction
Social justice
Patient satisfaction
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Materials/Supplies
Equipment/Software
Consultation(statistical)
Medical Condition Costs of Diabetes

Medical Condition Benefits

Higher rate of hospitalization (Moghissi et al., 2009) Improved glycemic control
Chronic complications related to diabetes
(AACE, 2011)
Longer LOS (Lange, 2010)

Cost avoided
Prevent hypoglycemia
Decrease LOS with improved management

More infections (Johnston & Van Horn, 2011)
Hypoglycemia treatment (Heaton, Martin &
Breljet, 2003)

Decrease readmissions
Accurate documentation, enhance coding,
therefore billing opportunity

Readmissions (AACE, 2011)

Table 4
ROI Analysis
Metric

Considerations

Costs
Benefits

Formula
Total Cost: $22, 503.00

Decrease episodes of
hypoglycemia, the mean cost
is $1186 per episode (Heaton,
Martin & Breljet, 2003)

16 episodes x 1186=$18,976
(16 episodes is the actual
number from baseline data)

Decrease LOS by one day on
10% of patients receiving care
using the toolkit, average cost
of care per day on the medical
unit is $1162 (actual data from
SJAHS)

8 patients x 1162=$9296

Total Benefit: $28,272.00
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Benefits-Costs
Costs
x 100%

36
28,272-22,503
22503
x 100%= 25%

Adapted from “Finance for Nurse Managers: Return on Investment”, by Patricia W. Stone,
Jennifer A. Smith, and Kevin D. Frick, 2010, American Nurse Today, 5 (3), 30-32.
Summary
To potentiate a successful systems change innovation the leader designed a
comprehensive evaluation plan to capture data and information to make future decisions related
to this innovation. A plan is essential when testing a new innovation that directly impacts patient
care in a hospital system. The leader assessed the organizational culture at SJAHS and
concluded that the diabetes EBP toolkit was consistent with the strategic plan to provide quality
patient care that is evidence-based and outcome focused. Other factors included in the
implementation plan included principles of economics and finances as illustrated by a budget and
ROI analysis. All of these factors are critical to address when implementing systems change.

AN INNOVATION TO TRANSFORM

37
Data Analysis

This study sample included 168 hospitalized patients on the medical unit during the
retrospective data collection time frames, each patient with a diabetes diagnosis and insulin
therapy. As shown in Table 5, the characteristics of the sample are illustrated. Seventy-eight
(46%) were female and 90 (54%) were male. The age range was 20-95, with a mean of 69.8
years. Figure 1, a histogram visually describes the age distribution. The majority of the patients
were Caucasian 150, (89%) and 17, (10%) were Native American.
One-hundred-sixty (95%) subjects had a diagnosis of Diabetes Mellitus Type 2 and eight
(5%) had a diagnosis of Diabetes Mellitus Type 1. Comorbidities are also noted in the table with
hypertension being the most common at 67%. The mean length of stay (LOS) was 3.53 days,
with a range of 1-16 days. Figure 2, a histogram visually describes the LOS distribution.
Table 5
Characteristics of Study Sample
Characteristics
Gender
Female
Male
Ethnic Group
Caucasian
Native American
Unknown
Diabetes Mellitus
Type 1
Type 2
Co-morbidities
Arrhythmia
Cardiovascular Disease
Chronic Renal Failure
Congestive Heart Failure
Coronary Artery Disease
Cerebral Vascular Accident
GERD
Hypercholesterolemia
Hyperlipidemia
Hypertension
Pulmonary Disease

N

%

78
90

(46)
(54)

150
17
1

(89)
(10)
(0.5)

8
160

(5)
(95)

15
42
30
30
37
18
25
8
43
113
47

(9)
(25)
(18)
(18)
(22)
(11)
(15)
(5)
(26)
(67)
(28)
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Histogram of Age
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Figure 1. Histogram of age visually describes the age distribution.

Histogram of LOS
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Figure 2. Histogram of LOS visually describes the LOS distribution.
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Findings by Research Question
Research question 1. Among medical adult hospitalized patients, does an
organizationally developed evidence-based diabetes care management toolkit in comparison to
current practice at SJAHS improve glycemic control? A total of 508 episodes of hyperglycemia
>180 mg/dL for 2010 and a total of 443 episodes of hyperglycemia >180 mg/dL for 2011 were
recorded. An individual value plot graph of the number of episodes of hyperglycemia visually
illustrates there was no obvious change in the episodes of hyperglycemia from 2010 to 2011.
See Figure 3.
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Figure 3. This individual plot diagram visually illustrates the total number of hyperglycemia
episodes >180mg/dL for 2010 and 2011 timeframes.
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A total of 16 episodes of hypoglycemia < 50 mg/dL for 2010 and a total of 9 episodes of
hypoglycemia < 50 mg/dL for 2011 were recorded. An individual value plot of the number of
episodes of hypoglycemia visually illustrates there was no obvious change in the episodes of
hypoglycemia from 2010 to 2011, note that the patient data values of zero (0) episodes are also
displayed on the graph. See Figure 4.
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Figure 4. This individual plot diagram visually illustrates the total number of hypoglycemia
episodes <50 mg/dL for 2010 and 2011 timeframes.
The outcome metric to measure glycemic control was the episodes of hyperglycemia >
180 mg/dL and the episodes of hypoglycemia <50 mg/dL per 1000 patient days. Patient day data
is a typical method of data reporting for quality improvement initiatives in the hospital setting.
As shown in Table 6, actual patient day data per month for SJAHS is used to calculate the rate of
hyperglycemia and hypoglycemia.
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Table 6
Data Summary of the Rate of Hyperglycemia and Hypoglycemia
Date
Jun10
Jul10
Aug10
Sep10
Oct10
Nov10
Jun11
Jul11
Aug11
Sep11
Oct11
Nov11

Episodes
Hyper180
111

Episodes
Hypo50
7

Patient
Days
557

Episodes/Patient
Days Hyper180a
0.199281867

Episodes/Patient Days
Hypo50b
0.012567325

114

1

514

0.221789883

0.001945525

68

1

485

0.140206186

0.002061856

86

5

445

0.193258427

0.011235955

93

2

485

0.191752577

0.004123711

36

0

457

0.078774617

0

93

2

486

0.191358025

0.004115226

106

0

449

0.236080178

0

63

3

454

0.13876652

0.00660793

45

2

463

0.097192225

0.004319654

67

0

453

0.14790287

0

62

2

446.25

0.138935574

0.004481793

Number of episodes of glucose greater than 180 mg/dL
Number of patient days
b Number of episodes of glucose less than 50 mg/dL
Number of patient days
a

Tests of normality were conducted on the two groups of data from 2010 and 2011 and for
the episodes of hyperglycemia and hypoglycemia per actual patient days for each month. All
four data sets passed the tests of normality so that a two-sample unequal variances t test could be
used to test each hypothesis.
Hyperglycemia
The results indicated there was not a significant decrease in glycemic control from pretoolkit implementation 2010 to post-toolkit implementation 2011. The toolkit did not improve
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glycemic control as measured by episodes of hyperglycemia >180 mg/dL per 1000 patient days.
A null hypothesis is supported by the data: P-Value = 0.339. See Table 7 for a summary of the
data.
Table 7
Hyperglycemia per 1000 patient days
Group

Na

Mean

StDev

2010

6

0.1708

0.0525

2011

6

0.1584

0.0485

aN

is the composite of data for 6 months from Table 6 for each time frame

Hypoglycemia
The results indicated there was not a significant decrease in glycemic control from pretoolkit implementation 2010 to post-toolkit implementation 2011. The toolkit did not improve
glycemic control as measured by episodes of hypoglycemia < 50 mg/dL per 1000 patient days.
A null hypothesis is supported by the data: P-Value = 0.210. See Table 8 for a summary of the
data.
Table 8
Hypoglycemia per 1000 patient days
Group

Na

Mean

StDev

2010

6

0.00532

0.00528

2011

6

0.00325

0.00268

aN

is the composite of data for 6 months from Table 6 for each timeframe
Research question 2. What are the effects of the toolkit on self-care goals and on patient

satisfaction? Descriptive statistics using percentage calculation illustrated if self-care goals were

AN INNOVATION TO TRANSFORM

43

identified at the time of discharge or not, see Table 9. The results indicated that only 14% of the
study sample had self-care goals identified at the time of discharge. 34% were not applicable
because those patients needed ongoing care management of their diabetes at a long term care
(LTC) facility and a process had not been established to develop a self-care goal with the patient
and the staff from the LTC facility.
Table 9
Self-Care Goals
Characteristics

N

%

Completed

11

(14)

Not completed

41

(52)

Not applicable

27

(34)

Descriptive statistics were also used to analyze patient satisfaction data. The study
sample was 11 (for question 5, only 7 responded with a ranking to the patient satisfaction
question). The responses were ranked on an ordinal scale. 1= very dissatisfied, 2=dissatisfied,
3=satisfied, and 4= very satisfied. The results indicated satisfaction, with mean scores for each
question of 3.0 or greater. See Table 10 for a summary of the data.
Table 10
Patient Satisfaction
Patient
Satisfaction
Question
Question 1
Question 2
Question 3
Question 4
Question 5

N

Minimum

Maximum

Mean

Std.
Deviation

11
11
11
11
7

3.00
3.00
2.00
3.00
2.00

4.00
4.00
4.00
4.00
4.00

3.3636
3.4545
3.0909
3.6364
3.0000

0.5045
0.5222
0.7006
0.5045
0.5773
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Research question 3. What was the protocol adherence for hypoglycemia management
during the post-toolkit implementation phase? The toolkit included a new hypoglycemia
treatment protocol. Of the nine episodes of hypoglycemia < 50 mg/dL, seven episodes (78%)
were managed following the protocol. Two episodes (22%) were noted not to follow the
protocol. There was no documentation in the chart to offer an explanation.
Research question 4. Does the toolkit decrease hospital readmissions? Of the 79
patients that received diabetes care management using the toolkit, zero were readmitted within
30 days from their date of discharge specifically for diabetes care. Thirteen patients were
readmitted within 30 days from their date of discharge for other medical reasons with diabetes
noted as a comorbidity.
Formative Evaluation
The diabetes EBP toolkit design team evaluated the toolkit during implementation with
the following conclusions noted. The toolkit was a good fit for the organization with its focus on
quality and evidence-based care. The toolkit was designed to ensure that all medical patients
received the same level of care for supporting our ministry of social justice. The design team felt
that the toolkit was feasible for implementation with the vision to improve care. The toolkit
study was well received by administration, the physicians, and the staff. Now that we have study
results the design team will now have the opportunity to further evaluate using formative
evaluation. Further evaluation is needed to determine the following; to what extent were the
toolkit components of care followed; what problems were encountered; how accepting was the
health care team; and were the metrics appropriate?
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Discussion, Conclusions, and Recommendations
Discussion
Findings for each research question are discussed and practice implications described.
Research question 1. Despite an evidence-based diabetes management toolkit,
multidisciplinary team involvement, and educational sessions for physicians and nurses the
results suggest that the toolkit did not improve glycemic control as evidenced by an insignificant
decrease in the episodes of hyperglycemia and hypoglycemia for the hospitalized medical patient
with diabetes. There are several factors that could have contributed to this finding; unclear roles,
communication barriers, and assumptions in regard to glycemic management between the
multidisciplinary team members. However, this systems change innovation was important for
the provision and promotion of quality care and clinically relevant in regards to establishing a
system and processes to support evidence-based care to improve patient outcomes.
Organizations need to improve glycemic control in the hospital setting and there is limited
research on what is the best approach.
The findings suggest a variety of practice implications for diabetes management at
SJAHS. Standardized orders for subcutaneous insulin therapy are a component of the toolkit.
This improves the ease of ordering insulin therapy and guides the physician to include all three
components; basal, prandial, and correction. However, the physicians still need to prescribe the
insulin therapy and adjust daily (Magaji & Johnston, 2011). The findings indicate improvement
is needed in daily adjustments to insulin regimens. This leader assumed that this would occur.
The toolkit order set was used on every patient in the study upon admission to the unit, but daily
modification did not occur on most of the patients. According to Modic (2010) there is often no
therapeutic adjustment in the insulin regimen throughout the patients’ hospital stay. A daily
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adjustment is a change in practice and requires multidisciplinary collaboration between nursing,
physicians, and the certified diabetes educator (CDE). This collaboration will promote the
prescription of basal, prandial, and correction insulin therapy to improve glycemic control. The
role of each team member at SJAHS may also be unclear in regards to who is responsible for
what aspect of the patients’ goal for glycemic control. Trending the effects of insulin therapy on
glycemic control and communicating those findings to the physician is a critical component of
nursing care (Modic, 2010). At SJAHS nursing needs to improve the process of communicating
blood sugar measurements and trends to the physicians. There appears to be an assumption by
nursing that the physicians are aware of the blood sugar measurements because of their
involvement in the plan of care. Communication and collaboration are essential for the
achievement of quality systems and patient outcomes (Tymkow, 2011). The study findings are
consistent with Johnston and VanHorn (2011) whereas glycemic control in a select group is in
need of improving the frequency of adjusting insulin therapy to improve glycemic control and
ultimately improve outcomes for the hospitalized patient with diabetes.
Research question 2. One of the most problematic findings was the poor documentation
of a self-care goal at the time of discharge, only 14% of the study sample had a goal noted. A
patient education/discharge instruction sheet was a component of the toolkit. This instruction
sheet was designed using the American Association of Diabetes Educators (AADE) (2004) selfcare key teaching points; healthy eating, being active, glucose monitoring, taking insulin,
problem solving, healthy coping, reducing risk, and identification of a self-care goal. This
instruction sheet was designed to be given on admission and reviewed collaboratively between
patient, family, and nurse at the time of discharge. Patient education is critical for the patient to
gain knowledge and skill to modify behavior to successfully manage their diabetes (AACE,
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2009). This was also a new process and may not yet be a mature process with the nursing staff
or nurses may feel unskilled to provide diabetes self-care patient education (Modic, 2010).
Nursing education was a component of the toolkit and included; an overview of diabetes, an
overview of patient education on diabetes self-care teaching points, and an overview of the
toolkit. One hundred percent of the nursing staff attended mandatory education, a two hour
didactic seminar in May of 2011 prior to toolkit implementation however this may require
ongoing intervention to promote competency in diabetes education. This finding warrants
further discussion with the nursing staff.
The patients appear to be satisfied with their diabetes care but due to the small sample
size one cannot make that assumption. In regards to question three, “how satisfied were you
with the treatment of your blood sugars” several of the patients offered a comment in response to
this question stating they were dissatisfied because they felt their blood sugars were too high. In
regards to question five, “upon discharge you set a diabetes self-care goal; how satisfied are you
with achieving this goal” several patients were unable to even respond to this question because
they did not set a goal upon discharge. This study question was designed to provide the patients’
with a voice for formative evaluation. This information requires further discussion with the
stakeholders.
Research question 3. Another potentially problematic finding relates to hypoglycemia
protocol adherence. In essence, the protocol is a physician order for nursing to follow when a
patient develops hypoglycemia. In this study 22% of the hypoglycemia episodes indicated that
the protocol was not adhered to. Upon chart review there was no order noted to support this nonadherence or any documentation in the nursing notes explaining the variation from the protocol.
Hypoglycemia is a safety concern and it is very important to treat the hypoglycemic patient per
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protocol. Interestingly this finding is not unique to SJAHS. According to Modic (2010), in two
studies with 484 episodes of hypoglycemia not one episode was treated according to preestablished protocols. This necessitates a need for further investigation related to nursing
practice and patient safety.
Research question 4. Of the 79 patients in the study who received care using the toolkit
zero were readmitted for diabetes within 30 days. Discharge planning was a key component of
the toolkit. However, one cannot assume this is solely related to the toolkit. There is no
baseline data to compare with. According to Brown (2009) 20% of all Medicare beneficiaries
discharged from the hospital are readmitted within 30 days. Patients are often readmitted with
problems that could have been prevented with adequate discharge planning, patient education,
and with a post-hospital patient monitoring plan. Is this an intervention that has generated a
readmission reduction for patients with diabetes and other co-morbidities? This data may
provide a starting point for determining what an effective transitional plan is when a patient is
discharged to home. This is data that will need to be monitored and trended overtime. This will
be an important metric to continue to gather data on because of its relevance to healthcare
reform. Beginning in October of 2012 Medicare payments may be reduced by certain
percentages for preventable readmissions. (Kaiser Family Foundation, 2011).
Study Limitations
Subjects most likely had variation in severity of diabetes, a variety of admission
diagnoses, pre-existing co-morbidities, physiological stressors, and variation in LOS which could
have affected glycemic control. Glycemic control may also have been impeded by inattention to
daily insulin therapy adjustments by the health care team, physician practice patterns, and
non-adherence to the hypoglycemic treatment protocol.
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The focus of this study was the noncritical care medical patient so the ability to
generalize to other patient populations is a limitation. The toolkit was also designed specifically
to improve diabetes care at SJAHS therefore generalizability is limited to other organizations.
The toolkit incorporated EBP, organizational values, and patient preferences for diabetes care at
SJAHS.
There was a design deficiency in regards to research question 2. What are the effects of
the toolkit on self-care goals? The metric really measured a person-centered process, whether or
not there was a self-care goal noted in the chart at the time of discharge? This reflects patient
education and discharge planning by the nurses not the effect of the toolkit on self-care.
The sample size selected for the patient satisfaction survey was too small. The survey
was developed by the leader and there was a desire to establish construct validity. According to
Polit and Beck (2008) ten respondents per item is the number most often recommended in the
literature. This would equate to a sample size of 50 for the patient satisfaction survey.
In regards to a systems change innovation, was the study limited by lack of maturity?
Does there need to be a period of time for the systems change innovation to mature before
measuring outcomes? Essentially in this study, the data collection began simultaneously with
implementation. In retrospect maybe outcomes research and metric measurements should have
started 3- 6 months after implementation? What is an appropriate timeframe? Should one
collect data at multiple time points to determine maturity? This is another area that needs further
investigation. However, we do have data to discuss, implications to ponder, and
recommendations to consider before making a decision in regards to the fate of the toolkit.
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Implications for Nursing Practice, Patient Care, Organizational Change, and EBP
The findings have implications for nursing practice, patient care, and organizational
change when implementing evidence-based practice. The practice implications and research
opportunities are endless for diabetes management of the hospitalized medical patient. For this
innovation, the implications identified are:
1. Nurses need to monitor and assess the patterns of hyperglycemia and inform the
physician so that they can make insulin therapy adjustments in a timely manner.
2. It is paramount for nursing to understand the importance of hypoglycemia management
(Ng et al., 2010). This also needs further investigation as to why nurses opt not to follow
an evidence-based hypoglycemia management protocol.
3. Nurses need to promote patient education on diabetes self-care and assist the patient to
identify a self-care goal at the time of discharge.
4. Nursing needs to be involved in the discharge planning process and collaborate with the
discharge planner to ensure a safe transition to home with patient self-care knowledge
and skill to promote successful diabetes management and prevent readmissions.
5. The diabetes health care team needs to determine the most effective and efficient way to
communicate episodes or patterns of hyperglycemia and hypoglycemia to improve
glycemic control. Nursing is a key member of this team and can contribute significantly
to its success by coordinating care and advocating for quality patient care. There needs to
be a focus on prescribing, monitoring, and improving communication practices in
conjunction with the use of the toolkit by all members of the health care team.
6. Patients have the right to receive quality evidence-based care. Patients also have the right
to receive equitable care at SJAHS. Nursing is responsible and accountable to protect the
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health, safety, and rights of the patient (Kalb, 2009). The toolkit was designed to provide
equitable, quality, safe, evidence-based patient care. The multidisciplinary team is
obligated to evaluate this toolkit and adapt the toolkit to ensure quality diabetes care is
provided at SJAHS.
7. According to Moghissi et al., (2009) inpatient diabetes management involves a systems
approach, is based upon evidence, is multidisciplinary, and includes patient education and
discharge planning. The toolkit and implementation plan was designed to encompass
these elements for diabetes management. The toolkit was also supported by the
organization, had multidisciplinary commitment, a vision, goals, strategic planning, and
an action plan for implementation. However, the findings suggest improvements or
adaptations are needed to support ongoing use of this innovation.
Melnyk and Fineout-Overholt (2011) note that persistence and patience are
needed in order for an innovative change to be successful. Projects are often terminated
too early because of the lack of persistence or patience. This innovation is currently in
transition and moving from a current state of practice to an improved state of practice.
From the challenges of implementation we can apply these learning’s by implementing
the identified practice implications with persistence and patience on the quest for
improved glycemic control. Further research is also needed on implementing change or
evidence-based practice in the health care system.
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Leadership Implications
As the leader of this innovation, self-reflection occurred during all phases of this project
but particularly during the evaluation phase with data analyses. From a leadership perspective
there appears to be some staff and physician resistance to systems change and despite potential
benefits for patient care this innovation has had some difficulty with adoption by all members of
the health care team. This was a complex innovation involving interplay between systems and
new processes including communication and decision making by members of the health care
team. This leader needs to provide feedback in regards to the study findings and implications so
that responsibilities of the health care team can be shared and decisions can be made for toolkit
adaptation (Melnyk & Fineout-Overholt, 2011). Additional effort is needed for diffusion of the
innovation to occur (Sanson-Fischer, 2004).
Evidence-based practice is a new concept and this leader needs to facilitate the
paradigm shift to an EBP culture at SJAHS and include the nursing staff and physician providers
in this transformation. There is current support from administration, managers, and leaders for
EBP. When nursing and physicians adopt EBP they will realize the significance of an innovation
to promote quality patient care. EBP leads to the highest quality of care and best outcomes
(Melnyk & Fineout-Overholt, 2011).
Conclusion
The findings of this study suggest that the toolkit has not been adopted by all members of
the health care team and glycemic control did not improve with use of the toolkit during the June
2011-November 2011 timeframe. Insulin therapy needs adjusting, education on self-care and
goal setting needs improvement, and the hypoglycemia protocol needs to be adhered to in order
to obtain improved glycemic control. The toolkit usage needs to be optimized and ultimately this
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will improve glycemic control for the hospitalized medical patient with diabetes. Organizations
can no longer ignore inadequate glycemic control or tolerate hyperglycemia and hypoglycemia in
the hospital setting. Glycemic control is a quality measure that needs further development and
investigation to ensure, safe, quality care for the hospitalized patient with diabetes.
Despite the results we have implemented a diabetes EBP toolkit that has the potential to
improve glycemic control. We have the elements to be successful; administrative support; an
organization that supports quality, safety, and EBP; a health care team that is committed to
quality diabetes care; a vision to provide this care; and an ethical and social justice
conscientiousness to do the right thing for the patient. Based upon the knowledge we have
gained from this innovation we are on a journey to improve diabetes care.
Recommendations
This transformational leader and future Doctor of Nursing Practice (DNP) nurse will:
1. Disseminate the research findings and key learning’s in a meaningful way to the
stakeholders, staff, physicians, and administrators at SJAHS. This leader will seek input
and feedback through dialogue and discussions to determine next steps in regards to the
toolkit.
2. Utilize a dashboard to report outcomes of the innovation to all staff at SJAHS.
Dashboards provide a summary of the care provided and a summary of our performance.
3. Complete formative and summative evaluation of the toolkit with the stakeholders;
include patient satisfaction data to capture the patient’s perspective of diabetes care using
the toolkit.
4. Determine decision quality; adopt, adapt, or retire the toolkit.
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5. Disseminate research findings and key leanings through a journal publication, podium or
poster presentation.
6. Continue to transform the model of nursing care at SJAHS to incorporate a culture that
embraces EBP and systems change. Leading change is one of the most important roles of
a leader (Stichler, 2011).
7. Utilize transformational leadership attributes including idealized influence, inspirational
motivation, intellectual stimulation, and individual consideration (Northouse, 2010).
DNP Transformation
This systems change project has provided this leader with an opportunity to learn the key
concepts and essential components of implementing systems change in a health care setting.
This study has helped this leader to understand the phenomena of EBP, systems change, and the
importance of leadership. As a future DNP this leader has built a new foundation of knowledge
for the future of health care leadership. This leader has expanded her wisdom, knowledge, and
abilities to be a more effective leader to transform nursing practice and patient care. As leaders
we will be faced with many new challenges as the landscape of health care changes. As a future
DNP I possess the essential knowledge and skill to generate new approaches to nursing practice,
patient care and the ability to effectively transform organizational systems change. We can
accomplish great things for the patients, the nursing profession, the communities we serve, and
the greater world with DNP leadership.
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Appendix A

Diabetes Evidence-Base Practice Toolkit a Sampling of the Components
Subcutaneous Insulin Orders
Hypoglycemia Protocol
Plan of Care
Page 4 of the Patient Education/Discharge Instruction Sheet
Discharge Planning Checklist
Outpatient Diabetes Education
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Subcutaneous Insulin Orders
Blood Glucose Monitoring
 QID – (AC & HS)  Other ________________________
Blood glucose level goals: 140 mg/dL or less

Other ______mg/dL

Subcutaneous Insulin Orders
 Basal insulin
 Levemir (Detemir) _____ units subq @ _____ hours
 Levemir (Detemir) _____ units twice daily subq @ _____ and _____
 Other __________________________________________________
 Prandial insulin (mealtime) (Hold if NPO or if BG < 60 mg/dL)
 NovoLog (Aspart) give immediately with a meal
_____ units subq 3 times daily with meals, OR
_____ units subq per 1 carbohydrate (one carb = 15 grams)
 Correction insulin (in addition to prandial dose above)
 NovoLog (Aspart)

 Other ________________

Glucose Level
 Low
 Med
 High
Less than 120 mg/dL
0 units
0 units
0 units
120-149 mg/dL
0 units
1 units
2 units
150-199 mg/dL
1 units
2 units
3 units
200-249 mg/dL
2 units
3 units
4 units
250-299 mg/dL
3 units
5 units
7 units
300-349 mg/dL
4 units
7 units
10 units
350 or greater & call
5 units
8 units
12 units
MD
 Bedtime (If blood glucose is less than 200 mg/dL, do not give correction dose;

 Individual
0 units
____ units
____ units
____ units
____ units
____ units
____ units

if greater than 200 mg/dL, give 50% of correction dose.
**DO NOT HOLD BASAL INSULIN UNLESS ORDERED BY THE MD.
** PRANDIAL dose can be administered once the patient completes 50% of their meal or within 30 minutes after meal.
** If patient eats less than 50% of meal, hold the PRANDIAL dose. Do give the HYPERglycemia correction insulin dose if
indicated.
**If a hypoglycemic event occurs, implement the HYPO glycemia Protocol.
**If patient status changes to NPO, call MD for new orders.
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Hypoglycemia Protocol
1.

Obtain stat Accu-Chek for s/s of hypoglycemia. If < 70 mg/dL proceed with the

following:
If conscious and able to swallow:
1. Give 15 grams of carbohydrate
•
4 oz of any juice
•
4 oz regular soda
•
15 gm of glucose gel
•
8 oz skim milk
2. Closely monitor patient’s response
3. Recheck blood glucose in 15 minutes
4. If less than 70 mg/dL, repeat 15 grams of
carbohydrate
5. May repeat this sequence 3 times
6. Notify physician if blood glucose remains less than 70
mg/dL
Recheck blood glucose 1 hour after blood glucose has
returned to a level greater than 70 mg/dL.

If unconscious or unable or unwilling to orally take
carbohydrate:
1. Give one amp of D50 (50 mls) IV x 1
2. If no IV access, give Glucagon 1 mg IM
3. Call covering physician.

Date: __________ Time: _______ Provider Signature: _______________________
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PLAN OF CARE
Problem # _____

Blood Glucose Level Abnormal – risk of/actual – State in which a person blood glucose level is outside normal
parameters
Related to:___________________________________________
Goal/Outcome
By discharge, the patient will:
•
•

•
•
•

Blood glucose levels within established parameters
Verbalizes knowledge of:
 Type of diabetes
 Healthy eating
 Physical activity
 Glucose monitoring
 Prescribed medication management
 Problem solving
 Healthy coping
 Reducing risk factor
 Important of post-discharge follow-up care
Describe priority life-styles changes he/she plans to implement
Self-care goal established
__________________________________________________

Nursing Interventions
•
•
•

•
•
•
•

Assess for signs and symptoms of hyperglycemia
Assess for signs and symptoms of hypoglycemia
Communication/referral as appropriate:
 Dietitian/CDE
 Pharmacist
 Discharge Planner
 Social Services
 ________________________________
Assess learning needs
Implement teaching plan
Provide education and printed materials from eClinical Reference Solutions/Mosby’s
Provide patient education on post-discharge follow-up care and signs/symptoms to report

Initiated by: __________________________ RN

Date: ______________________
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Sample of page 4 of the Patient Education/Discharge Instruction Sheet
A. Discharge

______

______

______

2. Symptoms to Report to Provider:
a. If your hands or feet are puffy
b. Blood sugars over 250 for 2-3 days or
blood sugars are below 70 more than 3
times in one week
c. Symptoms of high blood sugar, blurred
vision, increased thirst, increased
hunger, increased urination
d. Your blood sugar target should be
_______.
3. Keep Follow-up appointments as scheduled.

4. What is your Diabetes Self-Care Goal? Please write below:

________________________________________________________________________________
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DISCHARGE PLANNING CHECKLIST – DIABETIC PATIENT

Name _________________________________

Last hospital admission ___________________
Reason for admission ______________________________________________________
FOLLOW UP CARE/NEEDS:
Home Care referral
CDE Outpatient referral
Follow-up MD appointment
BARRIERS TO FOLLOW UP CARE AND/OR COMPLIANCE:
Payor source
Transportation
Financial
Ability to learn
Coping with lifestyle changes
Support – family/friends
RESOURCES:
Social Service consult
Support group information
Insulin assistance programs
Food Shelf
Online Resources
Transportation assistance
OTHER:

66
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OUTPATIENT DIABETES EDUCATION
ORDER FORM

5. Diagnosis (select one)






Type 1 – uncontrolled (250.03)
Type 1 – controlled (250.01)
Type 2 – uncontrolled (250.02)
Type 2 – controlled (250.00)
Other _____________________

2. Special Needs: (select only if applicable)
 Vision impaired
 Hearing impaired
 Physical limitations
 Cognitive impairment
 Language limitations ______________
 Other ___________________________

6. Orders for Diabetes Self-Management Training (DSMT) (select one)
 Comprehensive Education – Nurse Educator and Dietitian (10 hours Initial for Medicare)
 Follow up Education – Nurse Educator and Dietitian (2 hours for Medicare)
 Initiation of Insulin Therapy/Byetta
Orders ___________________________________________________________________
 Additional Insulin Training:

____Pen ____Syringe ____ Pump

 May refill Insulin Rx’s and diabetic supplies. (Monitoring strips, syringes, etc.)
 Continuous Blood Glucose Monitoring (CGMS)
 Provide Glucose Monitoring Device
7. Diabetes Self-Management Training (DSMT) Content to include:
 All 10 content areas, as appropriate: Monitoring diabetes; diabetes as a disease process;
psychological adjustment; physical activity; medical nutrition therapy; goal setting and problem
solving; medications; acute and chronic complication: prevention, detection and treatment;
preconception/pregnancy management/gestational diabetes management.
Other orders or information: ____________________________________________________
Date/Time: _____________________________
Provider Signature: ______________________
Appointment Date: ______________ Time: ______________ Location: ________________
Send or Fax orders to: Essentia Park Rapids Medical Records 218-732-2874.
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Appendix B
CAP Model

Adopted from General Electric Company, 200
2007 and Catholic Health Initiatives, 2009.
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Appendix C

Chart Audit Data Collection Tool
Date

Subject
Code

M
F

Ethnic
Group

Age

DM1
DM2

Comorbidities

Episodes of
Hyperglycemia
>180

Episodes of
Hypoglycemia
<50

□
□

Baseline
Post

Hypoglycemia
protocol
followed
Y-N-NA

Self-care
goal
identified
Y-N
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Appendix D

Patient Satisfaction
Interview Questions
1. How satisfied were you with the care you received for your diabetes during your last hospital stay?
1. Very dissatisfied

2. Dissatisfied

3. Satisfied

4. Very satisfied

2. How satisfied were you with the monitoring of your blood sugars?
1. Very dissatisfied

2. Dissatisfied

3. Satisfied

4. Very satisfied

3. How satisfied were you with the treatment of your blood sugars?
1. Very dissatisfied

2. Dissatisfied

3. Satisfied

4. Very satisfied

4. How satisfied were you with the staff’s knowledge of your diabetes treatment plan?
1. Very dissatisfied

2. Dissatisfied

3. Satisfied

4. Very satisfied

5. Upon discharge you set a diabetes self-care goal; how satisfied are you with achieving this goal?
1. Very dissatisfied

2. Dissatisfied

3. Satisfied

4. Very satisfied

6. Describe your discharge instructions. Did you receive information on your follow-up appointment
with a certified diabetes educator or your primary care provider or both? Who is it with and when?

7. Feel free to comment on your diabetes care at St. Joseph’s Area Health Services. Your feedback is
important.
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Appendix E
Consent

An Innovation to Transform Diabetes Care
RESEARCH INFORMATION AND CONSENT FORM
Introduction:
You are invited to participate in a research study to evaluate diabetes care. This study is being
conducted by Sonda Tolle RN, MS, and student in the Doctor of Nursing Practice Graduate Program at
St. Catherine University. You were selected as a possible participant in this research because you have
a diagnosis of diabetes and are hospitalized at St. Joseph’s Area Health Services. Please read this form
and ask questions before you decide whether to participate in the study.
Background Information:
The purpose of this study is to determine if an organizationally developed toolkit for the management of
diabetes improves blood sugar control in the hospital setting for the medical patient with diabetes.
Approximately 12 people are expected to participate in this research.
Procedures:
If you decide to participate, you will be asked to answer several questions related to your care while
hospitalized by phone 1-2 weeks post discharge. This study will take approximately 15 minutes of your
time.
Risks and Benefits:
The study has minimal risk; possible invasion of your privacy.
The benefits to participation are satisfaction that the information you provide may help others with
diabetes and hopefully improve diabetes care.
Confidentiality:
Any information obtained in connection with this research study that could identify you will be kept
confidential. In any written reports or publications, no one will be identified or identifiable and only
group data will be presented.
I will keep the research results in a password protected computer and/or a locked file cabinet in my
office and only I and my advisor will have access to the records while I work on this project. I will finish
analyzing the data by June 2012. I will then destroy all original reports and identifying information that
can be linked back to you
Voluntary nature of the study:
Participation in this research study is voluntary. Your decision whether or not to participate will not
affect your future relations with St. Joseph’s Area Health Services or St. Catherine University in any way.
During the interview process you may refuse to answer any question if you choose. If you decide to
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participate, you are free to stop at any time without affecting these relationships, and no further data
will be collected.
Contacts and questions:
If you have any questions, please feel free to contact me, Sonda Tolle at 218-255-2051. You may ask
questions now, or if you have any additional questions later, the faculty advisor, Corjena Cheung PhD,
RN at 651-690-6040, will be happy to answer them. If you have other questions or concerns regarding
the study and would like to talk to someone other than the researcher, you may also contact John
Schmitt, PhD, Chair of the St. Catherine University Institutional Review Board, at (651) 690-7739.
You may keep a copy of this form for your records.
Statement of Consent:
You are making a decision whether or not to participate. Your signature indicates that you have read
this information and your questions have been answered. Even after signing this form, please know that
you may withdraw from the study at any time and no further data will be collected.
______________________________________________________________________________

I consent to participate in the study.

_______________________________________________________________________
Signature of Participant

Date

_______________________________________________________________________
Signature of Researcher

Date

